SCFAs decrease the two important CRC signaling pathways nuclear factor kappa-B (NF-κB) and Wnt, facilitating anti-tumorigenic effects, and reduce pro-inflammatory cytokines such as TNF, IL-6 or CCL-3 [181]. This evidence concerns the gene IL6 and colorectal carcinoma.